February 9, 2024 · Form 4 insider transaction
Fenimore Christopher R. sold 1,342 shares of Regeneron Pharmaceuticals, Inc. at $953.47 per share, a transaction worth $1.28M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Represents volume-weighted average price of sales of 1,342 shares of Company stock on February 9, 2024 at prices ranging from $953.02 to $953.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.